Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Nov 22 GMED Reasons to Retain QIAGEN Stock in Your Portfolio for Now
Nov 21 GMED HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Nov 21 GMED ALGN Stock to Gain From CE Mark Win for Invisalign Palatal Expander
Nov 21 GMED GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
Nov 21 TGTX TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Nov 20 GMED These 19 stocks are poised for tax reform turbocharge - Jefferies
Nov 20 GMED End Market Growth, New Acquisitions Drive Thermo Fisher's Shares
Nov 20 GMED Stryker Stock May Gain From Oculan Lighting Platform's Launch
Nov 20 GMED ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
Nov 20 GMED ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio
Nov 19 GMED Patterson Companies Stock Up Following Latest Partnership Extension
Nov 19 GMED Medtronic Q2 Earnings and Revenues Top, Stock Down on Trimmed '25 View
Nov 19 GMED NVRO Stock Declines Despite Positive Study Data of Nevro1 System
Nov 19 GMED Reasons to Retain BSX Stock in Your Portfolio for Now
Nov 19 GMED BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
Nov 19 GMED Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Nov 18 GMED Globus Medical Stock: Re-Rated After A Solid Year
Nov 18 GMED INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
Nov 18 GMED LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint
Nov 18 GMED Here's Why You Should Add OMCL Stock to Your Portfolio Now
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags